142 related articles for article (PubMed ID: 21234630)
1. Prevalence of IgA class antibodies to cyclic citrullinated peptide (anti-CCP) in patients with primary Sjögren's syndrome, and its association to clinical manifestations.
Haga HJ; Andersen DT; Peen E
Clin Rheumatol; 2011 Mar; 30(3):369-72. PubMed ID: 21234630
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence and significance of immunoglobulin G-anti-cyclic citrullinated peptide antibodies in primary Sjogren's syndrome patients].
Liu Y; Wang YF; Wang KL; Lv FF
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):478-82. PubMed ID: 24943033
[TBL] [Abstract][Full Text] [Related]
3. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in Sjögren's syndrome.
Barcelos F; Abreu I; Patto JV; Trindade H; Teixeira A
Acta Reumatol Port; 2009; 34(4):608-12. PubMed ID: 20087267
[TBL] [Abstract][Full Text] [Related]
4. Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjögren's syndrome, and Wegener's granulomatosis.
Kamali S; Polat NG; Kasapoglu E; Gul A; Ocal L; Aral O; Konice M; Badur S; Inanc M
Clin Rheumatol; 2005 Nov; 24(6):673-6. PubMed ID: 15926038
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome.
Gottenberg JE; Mignot S; Nicaise-Rolland P; Cohen-Solal J; Aucouturier F; Goetz J; Labarre C; Meyer O; Sibilia J; Mariette X
Ann Rheum Dis; 2005 Jan; 64(1):114-7. PubMed ID: 15231509
[TBL] [Abstract][Full Text] [Related]
6. Follow-up of primary Sjogren's syndrome patients presenting positive anti-cyclic citrullinated peptides antibody.
Ryu YS; Park SH; Lee J; Kwok SK; Ju JH; Kim HY; Jeon CH
Rheumatol Int; 2013 Jun; 33(6):1443-6. PubMed ID: 23179261
[TBL] [Abstract][Full Text] [Related]
7. Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis.
Atzeni F; Sarzi-Puttini P; Lama N; Bonacci E; Bobbio-Pallavicini F; Montecucco C; Caporali R
Arthritis Res Ther; 2008; 10(3):R51. PubMed ID: 18462485
[TBL] [Abstract][Full Text] [Related]
8. [Significance of IgA isotype of anti-v-raf murine sarcoma viral oncogene homologue B1 antibody in rheumatoid arthritis].
Jin YJ; Sun L; Zhao JX; Liu XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):631-635. PubMed ID: 37534643
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of novel autoantibody isotypes against citrullinated-inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3)(542-556) peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis.
Liao CC; Chou PL; Cheng CW; Chang YS; Chi WM; Tsai KL; Chen WJ; Kung TS; Tai CC; Lee KW; Chen YC; Lin CY
J Proteomics; 2016 Jun; 141():1-11. PubMed ID: 27072115
[TBL] [Abstract][Full Text] [Related]
10. Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis.
Kokkonen H; Mullazehi M; Berglin E; Hallmans G; Wadell G; Rönnelid J; Rantapää-Dahlqvist S
Arthritis Res Ther; 2011 Feb; 13(1):R13. PubMed ID: 21291540
[TBL] [Abstract][Full Text] [Related]
11. Polyarthritis in primary Sjögren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up.
ter Borg EJ; Kelder JC
Clin Rheumatol; 2016 Mar; 35(3):649-55. PubMed ID: 26791875
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
[TBL] [Abstract][Full Text] [Related]
13. Clinical and diagnostic significance of serum immunoglobulin A rheumatoid factor in primary Sjogren's syndrome.
Lee KA; Kim KW; Kim BM; Won JY; Kim HA; Moon HW; Kim HR; Lee SH
Clin Oral Investig; 2019 Mar; 23(3):1415-1423. PubMed ID: 30032469
[TBL] [Abstract][Full Text] [Related]
14. IgA immunoglobulin isotype of rheumatoid factor in primary Sjögren's syndrome.
Maślińska M; Mańczak M; Kwiatkowska B; Ramsperger V; Shen L; Suresh L
Rheumatol Int; 2021 Mar; 41(3):643-649. PubMed ID: 33496802
[TBL] [Abstract][Full Text] [Related]
15. IgA rheumatoid factor in primary Sjogren's syndrome.
Peen E; Mellbye OJ; Haga HJ
Scand J Rheumatol; 2009; 38(1):46-9. PubMed ID: 18942022
[TBL] [Abstract][Full Text] [Related]
16. α-enolase is an antigenic target in primary Sjögren's syndrome.
Olivares-Martínez E; Hernández-Ramírez DF; Núñez-Álvarez CA; Llorente L; Hernandez-Molina G
Clin Exp Rheumatol; 2019; 37 Suppl 118(3):29-35. PubMed ID: 30418121
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis.
Ryu HJ; Takeuchi F; Kuwata S; Kim YJ; Lee EY; Lee EB; Song YW
Rheumatol Int; 2011 Mar; 31(3):315-9. PubMed ID: 20012964
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance of anti-cyclic citrullinated peptide antibody in primary Sjögren syndrome.
Kim SM; Park E; Lee JH; Lee SH; Kim HR
Rheumatol Int; 2012 Dec; 32(12):3963-7. PubMed ID: 22205381
[TBL] [Abstract][Full Text] [Related]
19. A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis.
Svärd A; Kastbom A; Söderlin MK; Reckner-Olsson Å; Skogh T
J Rheumatol; 2011 Jul; 38(7):1265-72. PubMed ID: 21459947
[TBL] [Abstract][Full Text] [Related]
20. Characterizing hand and wrist ultrasound pattern in primary Sjögren's syndrome: a case-control study.
Guedes LKN; Leon EP; Bocate TS; Bonfigliolli KR; Lourenço SV; Bonfa E; Pasoto SG
Clin Rheumatol; 2020 Jun; 39(6):1907-1918. PubMed ID: 32072351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
